Clinical Trial

Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2024 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study was to investigate the role of immunonutrion compared with standard nutrition in reducing oral mucositis in patients with locally advanced nasopharyngeal carcinoma.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-05-29.
Status change: Not Yet Recruiting → Recruiting 2024-08-05
Trial Details
NCT Number NCT05892354
Lead Sponsor First Affiliated Hospital of Guangxi Medical University
Collaborators: Guangdong Provincial People's Hospital, Zhejiang Cancer Hospital, Zhejiang Provincial People's Hospital, Fujian Cancer Hospital, Fujian Provincial Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, The First Affiliated Hospital of Nanchang University, Second Affiliated Hospital of Nanchang University, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Qingdao Central Hospital, Huizhou Municipal Central Hospital, Haikou People's Hospital, The Second Affiliated Hospital of Hainan Medical University, Zhejiang Provincial Tongde Hospital, Guilin Medical University, China, Liuzhou Workers' Hospital, Wuzhou Red Cross Hospital, Red Cross Hospital of Yulin City, First People's Hospital of Yulin, Hainan Cancer Hospital
Conditions Locally Advanced Nasopharyngeal Carcinoma
Enrollment 190 participants
Start Date 2023-06-12
Primary Completion 2025-04-30 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-07